Skip to main content

One Brave Idea

Dr. MacRae Discuss his ideas 2
Dr. MacRae and his team's
Dr. MacRae Discuss his ideas
Dr. MacRae and his team's winning idea group photo
Dr. MacRae

Through a $75 million investment over at least five years, the American Heart Association and Verily, with support from AstraZeneca, are embarking on a groundbreaking research enterprise focused on preventing or reversing coronary heart disease and, ultimately, improving and restoring cardiovascular health. This marks the start of a bold and new chapter as the largest one-time investment in a team with a focus to end coronary heart disease.

See what people are Saying

"THE BEST IDEA SHOULD TRIUMPH. IT COULD BE A TEENAGER IN WISCONSIN
WHO HAS A BRILLIANT IDEA."

- ANDY CONRAD, CEO, VERILY

"WE TRUST IN THE POTENTIAL OF IDEAS AND WILL PURSUE THEM, ALONE AND WITH OTHERS, UNTIL WE HAVE TRANSFORMED THE TREATMENT OF DISEASE."

- PASCAL SORIOT, CEO, ASTRAZENECA

"WE INTEND TO CHANGE THE WAY
CARDIOVASCULAR RESEARCH IS CONDUCTED."

- NANCY BROWN, CEO, AHA
American Heart Association Verily AstraZeneca
$75 MILLION + substantial resources and support from all three.
About Us